Mitchell Steiner
Vermögen: 2 Mio $ am 30.06.2026
Vermögen: 2 Mio $ am 30.06.2026
Mitchell Shuster Steiner was the founder of GTx, Inc., founded in 1997, where the titles held included Vice Chairman, Chief Executive Officer & CSO from 2011 to 2012.
Dr. Steiner was the founder of Aspen Park Pharmaceuticals, Inc., founded in 2014, where the titles held included Vice Chairman, President & Chief Executive Officer from 2014 to 2016.
Dr. Steiner currently holds the positions of Chairman, President & Chief Executive Officer at Veru, Inc. since 2018, Director at The Female Health Company (UK) Plc since 2016, and Independent Director at Mezzion Pharma Co., Ltd. since 2023.
Former positions include Professor at the University of Tennessee from 1995 to 2004, President-Urology at OPKO Health, Inc. from 2014 to 2016, and Assistant Professor at Vanderbilt University School of Medicine from 1993 to 1995.
Education includes undergraduate and doctorate degrees from Vanderbilt University and a doctorate degree from the University of Tennessee.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
VERU INC 4.42% | 04.05.2026 | 708’670 ( 4.42% ) | 2 Mio $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| VERU INC. | Vorstandsvorsitzender | 31.10.2016 |
| MEZZION PHARMA CO.,LTD. | Direktor/Vorstandsmitglied | 27.03.2020 |
The Female Health Company (UK) Plc
The Female Health Company (UK) Plc Miscellaneous ManufacturingProducer Manufacturing Manufactures and sells condom | Direktor/Vorstandsmitglied | 21.11.2016 |
| Unternehmen | Position | Ende |
|---|---|---|
Aspen Park Pharmaceuticals, Inc.
Aspen Park Pharmaceuticals, Inc. Medical DistributorsDistribution Services Develops and provides drugs | Gründer | 01.10.2016 |
| OPKO HEALTH, INC. | Corporate Officer/Principal | 01.01.2016 |
GTx, Inc.
GTx, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of small molecules for the treatment of cancer | Vorstandsvorsitzender | - |
University of Tennessee
University of Tennessee Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.01.2004 |
Vanderbilt University School of Medicine
Vanderbilt University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.01.1995 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 9 |
|---|---|
Veru, Inc.
Veru, Inc. Pharmaceuticals: MajorHealth Technology Manufactures, markets and sells female condoms and develops drugs for cancer treatment | Health Technology |
GTx, Inc.
GTx, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of small molecules for the treatment of cancer | Health Technology |
Aspen Park Pharmaceuticals, Inc.
Aspen Park Pharmaceuticals, Inc. Medical DistributorsDistribution Services Develops and provides drugs | Distribution Services |
Vanderbilt University
Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Tennessee
University of Tennessee Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OPKO Health, Inc.
OPKO Health, Inc. Medical/Nursing ServicesHealth Services Engages in biopharmaceutical and diagnostics | Health Services |
The Female Health Company (UK) Plc
The Female Health Company (UK) Plc Miscellaneous ManufacturingProducer Manufacturing Manufactures and sells condom | Producer Manufacturing |
Mezzion Pharma Co., Ltd.
Mezzion Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops, produces, and licenses pharmaceutical products | Health Technology |
Vanderbilt University School of Medicine
Vanderbilt University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen